Provided by Tiger Fintech (Singapore) Pte. Ltd.

Penumbra

291.82
-1.0200-0.35%
Post-market: 291.00-0.8200-0.28%18:16 EDT
Volume:679.03K
Turnover:199.58M
Market Cap:11.30B
PE:270.70
High:299.55
Open:293.49
Low:289.01
Close:292.84
Loading ...

TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada

Zacks
·
13 Dec 2024

QIAGEN Stock Gains Following the Latest Launch of IPA Interpret

Zacks
·
13 Dec 2024

Innovations and Buyouts Support BSX Stock Amid Macroeconomic Woes

Zacks
·
12 Dec 2024

Omnicell Introduces OmniSphere Platform, Stock to Gain

Zacks
·
12 Dec 2024

Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain?

Zacks
·
12 Dec 2024

Reasons to Retain Envista Stock in Your Portfolio for Now

Zacks
·
12 Dec 2024

Global Expansion to Support IDEXX Stock Despite Macroeconomic Issues

Zacks
·
11 Dec 2024

Penumbra Raised to Overweight From Equal-Weight by Wells Fargo

Dow Jones
·
11 Dec 2024

Wells Fargo Upgrades Penumbra to Overweight From Equalweight, Price Target is $190

MT Newswires Live
·
11 Dec 2024

Penumbra upgraded to Overweight from Equal Weight at Wells Fargo

TIPRANKS
·
11 Dec 2024

New NCCN Guidelines Boost Myriad Genetics' Prolaris: Stock to Gain?

Zacks
·
10 Dec 2024

Penumbra (PEN) is an Incredible Growth Stock: 3 Reasons Why

Zacks
·
10 Dec 2024

Penumbra Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
10 Dec 2024

Penumbra price target raised to $323 from $260 at Canaccord

TIPRANKS
·
09 Dec 2024

QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements

Zacks
·
09 Dec 2024

Why Penumbra (PEN) is a Top Growth Stock for the Long-Term

Zacks
·
06 Dec 2024

CRL Stock to Gain From the Global Biotech Incubator Program Launch

Zacks
·
06 Dec 2024

ZBH Stock Might Rise Following FDA Nod for Knee Implant Component

Zacks
·
05 Dec 2024

TMO Stock to Gain From the New Additions to CTS Portfolio of Products

Zacks
·
05 Dec 2024

Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?

Zacks
·
04 Dec 2024